Rameshbhai Meghjibhai Patel

Rameshbhai Meghjibhai Patel is a declared insider of Epigral Limited, with filings sourced from SEBI (PIT + SAST). We count 7 filings; the first trade dates from 29 November 2021 and the latest from 5 June 2023.

Every open-market trade on record is a purchase: 7 purchases worth €476k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2023: 3 purchases and no sales on the market.

In size, the median ticket on the buying side is €56k. On 4 out of 7 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The latest filing, published on 5 June 2023, reports an open-market purchase of €55k in Epigral Limited. The median gap between trade and publication is zero days: most filings appear on the same day. This delay matters because a trade only becomes useful information once it is public. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.